Brain Cancer Global Clinical Trials Review, H1, 2017

Market: Pharmaceuticals and Healthcare

Global, 317 pages report, published by GlobalData

Keywords : Brain Cancer Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO’s, Terminated, Suspended and Withdrawn trials of Brain Cancer, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.

Report ThumbnailMay-2017
Brain Cancer Global Clinical Trials Review, H1, 2017

Summary

GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Brain Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
  • List of Figures
  • Brain Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
  • Brain Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Brain Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Brain Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Brain Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Brain Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Brain Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14
  • Brain Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 15
  • Proportion of Brain Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 16
  • Brain Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Brain Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Brain Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 19
  • Brain Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Brain Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Brain Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
  • Brain Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
  • Brain Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Brain Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Brain Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Brain Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
  • Brain Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Brain Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
  • Brain Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
  • GlobalData Methodology 315
  • List of Tables
  • Brain Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 8
  • Brain Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Brain Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Brain Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Brain Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Brain Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Brain Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
  • Brain Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15
  • Proportion of Brain Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 16
  • Brain Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Brain Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Brain Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 19
  • Brain Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Brain Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Brain Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 22
  • Brain Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
  • Brain Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Brain Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Brain Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Brain Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Brain Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Brain Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
  • Brain Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
  • Table of Contents
  • Table of Contents 2
  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Brain Cancer to Oncology Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Brain Cancer to Oncology Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Brain Cancer Therapeutics Clinical Trials 29
  • Prominent Drugs 30
  • Latest Clinical Trials News on Brain Cancer 31
  • Apr 20, 2017: Medicenna to Present at Bloom Burton & Co. Healthcare Investor Conference 2017 31
  • Apr 13, 2017: FDA Allows NuvOx Pharma to Run a Phase II Clinical Trial in Brain Cancer 31
  • Apr 10, 2017: Novogen Update On Phase II Development Plans For GDC-0084 31
  • Mar 28, 2017: Blaze Bioscience Announces Tumor Paint BLZ-100 Publication in International Journal of Toxicology 32
  • Clinical Trial Profile Snapshots 33
  • Appendix 314
  • Abbreviations 314
  • Definitions 314
  • Research Methodology 315
  • Secondary Research 315
  • About GlobalData 316
  • Contact Us 316
  • Disclaimer 316
  • Source 317

Please select a license type

Share

Related Products

GlobalDataBrain Cancer Global Clinical Trials Review, H1, 2017Product ThumbnailBrain Cancer Global Clinical Trials Review, H1, 2017, Industry ReportProduct #: 828972
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved